RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,823 | +31.0% | 210,352 | -5.8% | 0.00% | 0.0% |
| Q2 2023 | $3,682 | +20.2% | 223,237 | +30.1% | 0.00% | – |
| Q1 2023 | $3,062 | +639.6% | 171,580 | +1108.3% | 0.00% | – |
| Q4 2022 | $414 | -99.9% | 14,200 | -12.9% | 0.00% | – |
| Q3 2022 | $400,000 | +168.5% | 16,300 | +26.4% | 0.00% | – |
| Q1 2022 | $149,000 | -31.7% | 12,900 | -22.8% | 0.00% | – |
| Q3 2021 | $218,000 | -33.3% | 16,712 | 0.0% | 0.00% | – |
| Q2 2021 | $327,000 | -0.6% | 16,712 | +8.1% | 0.00% | – |
| Q1 2021 | $329,000 | -27.5% | 15,465 | +1.3% | 0.00% | – |
| Q4 2020 | $454,000 | -97.6% | 15,270 | -98.2% | 0.00% | -100.0% |
| Q4 2019 | $19,217,000 | +3.9% | 836,985 | -2.3% | 0.00% | -33.3% |
| Q3 2019 | $18,488,000 | -21.6% | 856,324 | -20.1% | 0.00% | 0.0% |
| Q2 2019 | $23,585,000 | -14.6% | 1,072,041 | +6.4% | 0.00% | -25.0% |
| Q1 2019 | $27,613,000 | +29.5% | 1,007,416 | +27.0% | 0.00% | 0.0% |
| Q4 2018 | $21,323,000 | -7.5% | 793,274 | +0.4% | 0.00% | +33.3% |
| Q3 2018 | $23,045,000 | +33.1% | 790,015 | +42.6% | 0.00% | 0.0% |
| Q2 2018 | $17,314,000 | +105.7% | 553,885 | +30.9% | 0.00% | +200.0% |
| Q1 2018 | $8,419,000 | -4.7% | 423,049 | +39.1% | 0.00% | 0.0% |
| Q4 2017 | $8,838,000 | – | 304,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |